Recent epidemiological evidence showed that mutations to the HFE-63 allele of this hemochromatosis-associated iron-assimilation protein improve chances of avoiding Alzheimer's disease (AD). This is unexpected since increased brain ferroptosis in gray-matter increases the risk for vascular dementia and AD. However, diffusion tensor imaging from a key Alzheimer's Disease Neuroimaging Initiative biomarker study showed that the hemochromatosis H63D allele protected white matter tracts and improved cognitive performance in individuals when APOE4 accelerates AD. H63D-carrying individuals exhibit elevated serum ferritin levels. We suggest coordinate increased levels of H-ferritin in iron-rich oligodendrocytes in H63D carriers generates sufficient neuroprotection to enhance myelin sheath integrity in white matter axons.
PangRWangJKanekarS, et al.Linking genetics to MRI-DTI: HFE polymorphism delays Alzheimer's disease white matter degeneration in APOE4 carriers. J Alzheimers Dis2025; 107: 1114–1128.
3.
CasanovaFTianQWilliamsonDS, et al.MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: observational and genetic analysis in the UK Biobank cohort. Neurobiol Dis2024; 197: 106539.
4.
CasanovaFTianQAtkinsJL, et al.Iron and risk of dementia: Mendelian randomisation analysis in UK Biobank. J Med Genet2024; 61: 435–442.
5.
AtkinsJLPillingLCHealesCJ, et al.Hemochromatosis mutations, brain iron imaging, and dementia in the UK Biobank cohort. J Alzheimers Dis2021; 79: 1203–1211.
6.
OlynykJKTrinderDRammGA, et al.Hereditary hemochromatosis in the post-HFE era. Hepatology2008; 48: 991–1001.
7.
SampietroMCaputoLCasattaA, et al.The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol Aging2001; 22: 563–568.
8.
ConnorJRMilwardEAMoalemS, et al.Is hemochromatosis a risk factor for Alzheimer's disease?J Alzheimers Dis2001; 3: 471–477.
9.
LardelliM. An alternative view of familial Alzheimer's disease genetics. J Alzheimers Dis2023; 96: 13–39.
10.
ThorwaldMAGodoy-LugoJAKerstiensE, et al.Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis. Alzheimers Dement2025; 21: e70322.
11.
ThorwaldMAGodoy-LugoJAGarciaG, et al.Iron-associated lipid peroxidation in Alzheimer's disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice. Alzheimers Dement2025; 21: e14541.
12.
CheliVTCorrealeJPaezPM, et al.Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro2020; 12: 1759091420962681.
13.
WadeQWConnorJR. What does iron mean to an oligodendrocyte?Glia2025; 73: 1784–1804.
14.
BartzokisGTishlerTALuPH, et al.Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging2007; 28: 414–423.
15.
BartzokisGLuPHTishlerTA, et al.Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res2007; 32: 1655–1664.
16.
WolozinBGoltsN. Iron and Parkinson's disease. Neuroscientist2002; 8: 22–32.
17.
ZhangPChenLZhaoQ, et al.Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's disease. Free Radic Biol Med2020; 152: 227–234.
18.
RogersJTCahillCM. Iron-responsive-like elements and neurodegenerative ferroptosis. Learn Mem2020; 27: 395–413.
19.
WangZJinMHongW, et al.Learnings about Abeta from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeutics. Acta Neuropathol Commun2023; 11: 39.
20.
Plascencia-VillaGPonceACollingwoodJF, et al.High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease. Sci Rep2016; 6: 24873.
21.
SchubertDChevionM. The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun1995; 216: 702–707.
22.
XuHPerreauVMDentKA, et al.Iron regulates apolipoprotein E expression and secretion in neurons and astrocytes. J Alzheimers Dis2016; 51: 471–487.
23.
Ali-RahmaniFGrigsonPSLeeS, et al.H63d mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment. Neurobiol Aging2014; 35: 1511 e1–12.
24.
AytonSFauxNGBushAI, et al.Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun2015; 6: 6760.
25.
CahillCMSarangSSBakshiR, et al.Neuroprotective strategies and cell-based biomarkers for manganese-induced toxicity in human neuroblastoma (SH-SY5Y) cells. Biomolecules2024; 14: 647.
26.
RogersJTVenkataramaniVWashburnC, et al.A role for amyloid precursor protein translation to restore iron homeostasis and ameliorate lead (Pb) neurotoxicity. J Neurochem2016; 138: 479–494.
27.
ChoHHCahillCMVanderburgCR, et al.Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J Biol Chem2010; 285: 31217–31232.
28.
AytonSLeiPHareDJ, et al.Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J Neurosci2015; 35: 3591–3597.
29.
DuceJATsatsanisACaterMA, et al.Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell2010; 142: 857–867.
30.
VenkataramaniVDoeppnerTRWillkommenD, et al.Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin. J Neurochem2018; 147: 831–848.
31.
Marshall MosconSNeelyEProctorE, et al.A common variant in the iron regulatory gene (Hfe) alters the metabolic and transcriptional landscape in brain regions vulnerable to neurodegeneration. J Neurochem2024; 168: 3132–3153.
32.
FujiiHTakagakiNYohT, et al.Non-prescription supplement-induced hepatitis with hyperferritinemia and mutation (H63D) in the HFE gene. Hepatol Res2008; 38: 319–323.
33.
KaurDYantiriFRajagopalanS, et al.Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron2003; 37: 899–909.
34.
MattsonMPGuoZHGeigerJD. Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem1999; 73: 532–537.
35.
RemesalLSucharov-CostaJWuY, et al.Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment. Nat Aging2025; 5: 1957–1969.
36.
Marshall MosconSLConnorJR. HFE Mutations in neurodegenerative disease as a model of hormesis. Int J Mol Sci2024; 25: 3334.
37.
TibodeauJDFoxPMRoppPA, et al.The up-regulation of ferritin expression using a small-molecule ligand to the native mRNA. Proc Natl Acad Sci U S A2006; 103: 253–257.
38.
RogersJTXiaNWongA, et al.Targeting the iron-response elements of the mRNAs for the Alzheimer's amyloid precursor protein and ferritin to treat acute lead and manganese neurotoxicity. Int J Mol Sci2019; 20: 994.
